Literature DB >> 17120178

Bone microarchitecture in males with corticosteroid-induced osteoporosis.

D Chappard1, N Josselin, C Rougé-Maillart, E Legrand, M F Baslé, M Audran.   

Abstract

SUMMARY: Microarchitectural changes in trabecular bone were analyzed by microcomputed tomography (microCT) and histomorphometry in 24 patients with corticosteroid-induced osteoporosis. The microCT images revealed a reduction in trabecular thickness only on frequency distribution curves, with no increase in trabecular separation. Trabecular plate thinning and perforations were easily identified.
INTRODUCTION: Corticosteroid-induced osteoporosis (CSIOP) is mediated by direct actions of the drug on bone cells. The result is a decrease in trabecular bone mass and a reduction in trabecular thickness, but connectivity is believed to remain rather well preserved.
METHODS: Twenty-four transiliac bone biopsies from patients with CSIOP were studied conjointly by histomorphometry [with two-dimensional (2D) architectural descriptors] and microCT (with 3D analysis of trabecular characteristics, including trabecular thickness and separation). The frequency distribution of thickness and separation were compared with data obtained in nine control subjects.
RESULTS: 2D histomorphometry revealed a decrease in bone volume and trabecular thickness in the bone biopsies of the CSIOP patients when compared to those of the controls. MicroCT appeared to be able to identify the reduction in thickness only when the frequency distribution of trabecular thickness was computed. No difference for the curves of the frequency distribution of trabecular separation was evidenced between patients and controls. MicroCT and 2D histomorphometric results were correlated, but 2D analysis appeared to be more sensitive. However, microCT identified a very specific thinning of the trabecular plates in their center that corresponds to the earlier stages of perforations.
CONCLUSION: Trabecular plate thinning can be observed and perforations occur on very thin plates in CSIOP patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120178     DOI: 10.1007/s00198-006-0278-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  37 in total

1.  The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography.

Authors:  A Barbier; C Martel; M C de Vernejoul; F Tirode; M Nys; G Mocaer; C Morieux; H Murakami; F Lacheretz
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

2.  Three-dimensional analysis of nonhuman primate trabecular architecture using micro-computed tomography.

Authors:  R J Fajardo; R Müller
Journal:  Am J Phys Anthropol       Date:  2001-08       Impact factor: 2.868

Review 3.  Connectivity of cancellous bone: assessment and mechanical implications.

Authors:  J E Compston
Journal:  Bone       Date:  1994 Sep-Oct       Impact factor: 4.398

4.  Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor, and marrow space star volume.

Authors:  P I Croucher; N J Garrahan; J E Compston
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

Review 5.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

Review 6.  Star volume in bone research. A histomorphometric analysis of trabecular bone structure using vertical sections.

Authors:  A Vesterby
Journal:  Anat Rec       Date:  1993-02

7.  Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.

Authors:  N E Lane; D B Kimmel; M H Nilsson; F E Cohen; S Newton; R A Nissenson; G J Strewler
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

8.  Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.

Authors:  D Chappard; E Legrand; M F Basle; P Fromont; J L Racineux; A Rebel; M Audran
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

9.  Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.

Authors:  A L Dolan; C Moniz; B Dasgupta; F Li; C Mackintosh; P Todd; V Corrigall; G S Panayi
Journal:  Arthritis Rheum       Date:  1997-11

10.  Precision and accuracy of peripheral quantitative computed tomography (pQCT) in the mouse skeleton compared with histology and microcomputed tomography (microCT).

Authors:  Corina Schmidt; Matthias Priemel; Thomas Kohler; Axel Weusten; Ralph Müller; Michael Amling; Felix Eckstein
Journal:  J Bone Miner Res       Date:  2003-08       Impact factor: 6.741

View more
  10 in total

1.  Ultrastructural characteristics of glucocorticoid-induced osteoporosis.

Authors:  B Bouvard; M Audran; E Legrand; D Chappard
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

Review 2.  New laboratory tools in the assessment of bone quality.

Authors:  D Chappard; M F Baslé; E Legrand; M Audran
Journal:  Osteoporos Int       Date:  2011-02-24       Impact factor: 4.507

3.  Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids.

Authors:  Stephanie Sutter; Kyle K Nishiyama; Anna Kepley; Bin Zhou; Ji Wang; Donald J McMahon; X Edward Guo; Emily M Stein
Journal:  J Clin Endocrinol Metab       Date:  2014-08-15       Impact factor: 5.958

4.  Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.

Authors:  Y Liu; E Dimango; M Bucovsky; S Agarwal; K Nishiyama; X E Guo; E Shane; E M Stein
Journal:  Osteoporos Int       Date:  2018-06-11       Impact factor: 4.507

5.  Expression Profiling of Selected Immune Genes and Trabecular Microarchitecture in Breast Cancer Skeletal Metastases Model: Effect of α-Tocopherol Acetate Supplementation.

Authors:  Riadh Badraoui; Mohd Saeed; Nouha Bouali; Walid S Hamadou; Salem Elkahoui; Mohammad J Alam; Arif J Siddiqui; Mohd Adnan; Mongi Saoudi; Tarek Rebai
Journal:  Calcif Tissue Int       Date:  2022-01-06       Impact factor: 4.333

6.  Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA.

Authors:  Christian Heiss; Parameswari Govindarajan; Gudrun Schlewitz; Nasr Y A Hemdan; Nathalie Schliefke; Volker Alt; Ulrich Thormann; Katrin Susanne Lips; Sabine Wenisch; Alexander C Langheinrich; Daniel Zahner; Reinhard Schnettler
Journal:  Med Sci Monit       Date:  2012-06

7.  Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality.

Authors:  L Xi; P De Falco; E Barbieri; A Karunaratne; L Bentley; C T Esapa; N J Terrill; S D M Brown; R D Cox; G R Davis; N M Pugno; R V Thakker; H S Gupta
Journal:  Acta Biomater       Date:  2018-06-15       Impact factor: 8.947

8.  The correlation between phalangeal quantitative ultrasonography and dual energy x-ray absorptiometry in women with premature ovarian failure.

Authors:  Tandip S Mann; Alison H McGregor; Rajesh Patel
Journal:  Mcgill J Med       Date:  2008-07

9.  3D Porous Architecture of Stacks of β-TCP Granules Compared with That of Trabecular Bone: A microCT, Vector Analysis, and Compression Study.

Authors:  Daniel Chappard; Lisa Terranova; Romain Mallet; Philippe Mercier
Journal:  Front Endocrinol (Lausanne)       Date:  2015-10-12       Impact factor: 5.555

10.  Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.

Authors:  Claus-C Glüer; Fernando Marin; Johann D Ringe; Federico Hawkins; Rüdiger Möricke; Nikolaos Papaioannu; Parvis Farahmand; Salvatore Minisola; Guillermo Martínez; Joan M Nolla; Christopher Niedhart; Nuria Guañabens; Ranuccio Nuti; Emilio Martín-Mola; Friederike Thomasius; Georgios Kapetanos; Jaime Peña; Christian Graeff; Helmut Petto; Beatriz Sanz; Andreas Reisinger; Philippe K Zysset
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.